Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Kouraklis · SciRah

Researcher profile · Semantic Scholar

A. Kouraklis

Share profile

A. Kouraklis — researcher profile on SciRah

h-index: 9
Works: 43
Citations: 626

Most-cited papers

Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response.
F. Panitsas, M. Theodoropoulou, A. Kouraklis, M. Karakantza +4 more
2004Blood253 citations
Semantic Scholar
Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients
E. Terpos, A. Mougiou, A. Kouraklis, A. Chatzivassili +20 more
2002British Journal of Haematology107 citations Open access
Semantic Scholar
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients
E. Katodritou, E. Terpos, A. Symeonidis, A. Pouli +22 more
2014American journal of hematology/oncology57 citations Open access
Semantic Scholar
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience
E. Katodritou, E. Terpos, E. Kastritis, Sossana Delimpasis +25 more
2015Annals of Hematology52 citations
Semantic Scholar
Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera
M. Karakantza, Nikolaos C. Giannakoulas, P. Zikos, G. Sakellaropoulos +6 more
2004International journal of hematology40 citations
Semantic Scholar
The incidence of myelodysplastic syndromes in Western Greece is increasing
C. Avgerinou, Y. Alamanos, P. Zikos, P. Lampropoulou +9 more
2013Annals of Hematology33 citations Open access
Semantic Scholar
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias
A. Taher, R. Origa, S. Perrotta, A. Kouraklis +7 more
2018Health and Quality of Life Outcomes25 citations Open access
Semantic Scholar
Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12‐year study
S. Delicou, K. Manganas, M. Diamantidis, T. Venou +29 more
2025British Journal of Haematology10 citations
Semantic Scholar
Clinical Features, Outcome and Prognostic Factors For Survival and Evolution To Multiple Myeloma Of Solitary Plasmacytomas: A Report Of The Greek Myeloma Study Group In 97 Patients
E. Terpos, A. Symeonidis, A. Pouli, C. Kelaidi +19 more
201310 citations
Semantic Scholar
Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II E.C.L.I.P.S.E. Study
A. Taher, R. Origa, S. Perrotta, A. Kouraklis +8 more
20166 citations
Semantic Scholar
New Film-Coated Tablet Formulation of Deferasirox Is Well Tolerated in Patients with Thalassemia or MDS: Results of the Randomized, Phase II E.C.L.I.P.S.E. Study
A. Taher, R. Origa, S. Perrotta, A. Kouraklis +8 more
20166 citations Open access
Semantic Scholar
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response
N. Viniou, E. Terpos, A. Galanopoulos, E. Kritikou-Griva +13 more
2002Annals of Hematology6 citations
Semantic Scholar
Influence of patient‐reported outcomes on the treatment effect of deferasirox film‐coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis
A. Taher, R. Origa, S. Perrotta, A. Kouraklis +7 more
2019American journal of hematology/oncology5 citations Open access
Semantic Scholar
Choroidal Thickness Evaluation in a Transfusion-Dependent Beta-Thalassemia Greek Population
F. Tsapardoni, Olga E. Makri, V. Lazaris, V. Labropoulou +5 more
2020Clinical Ophthalmology4 citations Open access
Semantic Scholar
319 Response to treatment with erythropoietin in patients with MDS highly predicts low risk of evolution to AML and longer survival
A. Symeonidis, P. Zikos, A. Galanopoulos, I. Kotsianidis +10 more
20113 citations
Semantic Scholar
Treatment of anemia in myelodysplastic syndromes with prolonged administration of erythropoietin or erythropoietin and granulocyte colony-stimulating factor
E. Terpos, A. Mougiou, N. Stavroyianni, A. Kouraklis +15 more
20003 citations
Semantic Scholar
67 Response to ESA treatment in patients with MDS: Determination of a predictive score, from a retrospective analysis of 669 patients
A. Symeonidis, P. Zikos, A. Galanopoulos, I. Kotsianidis +11 more
20112 citations
Semantic Scholar
Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease
A. Symeonidis, M. Liga, E. Triantafyllou, A. Kouraklis +4 more
2011Bone Marrow Transplantation2 citations Open access
Semantic Scholar
P103 Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group
A. Kouraklis, A. Symeonidis, A. Galanopoulos, G. Kaiafa +7 more
20091 citations
Semantic Scholar
PS1192 INITIAL REPORT OF A NILOTINIB DISCONTINUATION PROJECT WITH 54 GREEK CML PATIENTS FOLLOWED IN ACCORDANCE TO THE APPROVED DISCONTINUATION INDICATION OF THE DRUG
M. Dimou, M. Roumelioti, Tasoula Touloumenidou, A. Stefanou +8 more
2019HemaSphere0 citations Open access
Semantic Scholar
S840 IMPACT OF 1ST LINE TREATMENT ON OVERALL SURVIVAL IN 1.633 PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA – A MULTINATIONAL COLLABORATIVE EFFORT COORDINATED BY THE AGMT STUDY GROUP
L. Pleyer, M. Leisch, A. Kouraklis, E. Padron +35 more
2019HemaSphere0 citations Open access
Semantic Scholar
Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study
D. Sotiropoulos, V. Papadopoulos, M. Dimou, D. Kyriakou +14 more
20150 citations
Semantic Scholar
No Survival Improvement for Central Nervous System Multiple Myeloma By the Use of Novel Anti-Myeloma Agents: The Greek Myeloma Study Group Experience
E. Katodritou, E. Terpos, S. Delimpasi, A. Symeonidis +19 more
20140 citations
Semantic Scholar
Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic Strategy
D. Sotiropoulos, A. Symeonidis, V. Papadopoulos, P. Tsirigotis +19 more
20140 citations
Semantic Scholar
P-260 Exposure to pesticides is a major risk factor for myelodysplastic syndromes (MDS) in Southwestern Greece
C. Avgerinou, A. Kouraklis, S. Theodoropoulou, I. Giannezi +8 more
20130 citations
Semantic Scholar
Greek Registry Of Essential Thrombocythemia: Baseline Characteristics and Therapeutic Strategy
D. Sotiropoulos, A. Symeonidis, V. Papadopoulos, P. Tsirigotis +29 more
20130 citations
Semantic Scholar
Rituximab Is Highly Effective In The Treatment Of Patients With Autoimmune Blood Cytopenias, Particularly When It Is Followed By a Post-Induction Consolidation / Maintenance Phase
N. Giannakoulas, E. Kapsali, A. Christoforidou, Zoe Topouzoglou +7 more
20130 citations
Semantic Scholar
manifestation of a type-1 polarized immune response Adult chronic idiopathic thrombocytopenic purpura (ITP) is the
N. Zoumbos, A. Maniatis, A. Mouzaki, F. Panitsas +4 more
20130 citations
Semantic Scholar
Occurrence of Neoplastic Diseases in a Large Cohort of Thalassemic Patients in Greece
A. Kouraklis, Antonia Chatziliami, A. Kattamis, E. Vlachaki +6 more
20120 citations
Semantic Scholar
140 Incidence of myelodysplastic syndromes in a well-defined population of Southwestern Greece
C. Avgerinou, Y. Alamanos, P. Zikos, I. Tavernarakis +6 more
20110 citations
Semantic Scholar
224 Factors affecting leukemic transformation in patients with del-5q treated with lenalidomide
A. Symeonidis, A. Galanopoulos, E. Hatzimichail, C. Loukidis +12 more
20110 citations
Semantic Scholar
141 A case-control study to investigate risk factors for myelodysplastic syndromes in Southwestern Greece
C. Avgerinou, Vasileios Lazaris, Y. Alamanos, A. Kouraklis +2 more
20110 citations
Semantic Scholar
P113 Treatment with lenalidomide for patients with myelodysplastic syndromes (MDS): report of the Hellenic experience on 73 patients. A retrospective analysis of the Hellenic MDS Study Group
A. Symeonidis, A. Galanopoulos, E. Hatzimichael, A. Kouraklis +13 more
20090 citations
Semantic Scholar
Impaired T-Lymphocyte Subpopulations and Deranged Profile of Immunologic Activation in Patients with Gaucher Disease Type I
A. Symeonidis, G. Theodorou, C. Repa, T. Marinakis +4 more
20080 citations
Semantic Scholar
P026 Different pattern of JNK activity in MDS-related versus de novo AML: implications for apoptosis-resistance and treatment failure in MDS-related AML
E. D. Lagadinou, P. G. Ziros, O. Tsopra, A. Klamargias +5 more
20070 citations
Semantic Scholar
C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.
E. Lagadinou, Panos G. Ziros, O. Tsopra, E. Thanopoulou +3 more
20060 citations
Semantic Scholar
Anemia Associated with Chronic Disease in Patients with Chronic Lymphocytic Leukemia Is Not Attributed to Decreased Production or Impaired EPO Signaling of Erythroid Precursors.
O. Tsopra, Panos G. Ziros, E. Lagadinou, A. Kouraklis +4 more
20060 citations
Semantic Scholar
P-16 Determination of the response toanemia index (RAI) in patients with MDS. Recognition of this parameter as a major predictor of in vivo response to treatment with rh-EPO
A. Symeonidis, M. Leotsinidis, A. Kouraklis, N. Zoumbos
20050 citations
Semantic Scholar
P-36 Trisomy 8 alone in myelodysplasticsyndromes: Recognition of the common clinico-hematologic features from 109 patients
A. Symeonidis, T. Marinakis, H. Papadakis, A. Kouraklis +7 more
20050 citations
Semantic Scholar
P-15 Chronic myelomonocytic leukemia:IPSS best discriminates patients with worse prognosis, in both the dysplastic and the proliferative subtype
A. Symeonidis, V. Lambropoulou, E. Michalis, A. Chatzivassilis +6 more
20050 citations
Semantic Scholar
Peripheral Blood Dendritic Cell Subsets of Patients with Type I Gaucher’s Disease Are Decreased in Number but Functionally Normal.
A. Symeonidis, Ilina Mitseva, T. Marinakis, C. Repa +3 more
20040 citations
Semantic Scholar
Neither the Response of Committed Progenitors to Growth Factors nor the Detection of Apoptosis in Bone Marrow Cells Can Predict the Clinical Response to Treatment in Patients with Rars.
A. Kouraklis, A. Symeonidis, E. Thanopoulou, P. Tsoplou +2 more
20040 citations
Semantic Scholar
Severe bone toxicity in young patients with Hodgkins disease treated with the BEACOPP regimen
A. Symeonidis, A. Kouraklis, E. Fragopanagou, N. Giannakoulas +3 more
20010 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Zoumbos×18
Invite
N. Zoumbos — researcher profile on SciRah
A. Symeonidis×16
Invite
A. Symeonidis — researcher profile on SciRah
A. Symeonidis×13
Invite
A. Symeonidis — researcher profile on SciRah
N. Anagnostopoulos×11
Invite
N. Anagnostopoulos — researcher profile on SciRah

×10

Invite

E. Terpos — researcher profile on SciRah

M. Karakantza×9

Invite

M. Karakantza — researcher profile on SciRah

A. Galanopoulos×9

Invite

A. Galanopoulos — researcher profile on SciRah

Invite

N. Viniou — researcher profile on SciRah

M. Kotsopoulou×7

Invite

M. Kotsopoulou — researcher profile on SciRah

A. Anagnostopoulos×7

Invite

A. Anagnostopoulos — researcher profile on SciRah

Invite

P. Zikos — researcher profile on SciRah

N. Giannakoulas×6

Invite

N. Giannakoulas — researcher profile on SciRah